SUNRISE, FL – Bioheart, Inc., (NASDAQ:BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, says it has received a $1 million unsecured loan from Rogers Telecommunications Limited.

Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

It recently entered into an agreement to acquire Medicalalgorithmics and the POCKETECG intelligent heart monitor and diagnostic system.

Also this summer, it secured worldwide non-exclusive distribution rights to the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home intelligent device designed specifically to improve available healthcare to patients outside hospitals who are suffering from heart failure.

On the Web: www.bioheart.com

Related Stories:

• Florida-based Bioheart to buy Medicalalgorithmics
• South Korean firm invests $4M in BioHeart
• Florida’s BioHeart names Mike Tomas president, CEO
• Bioheart plans $35 million IPO
• Florida’s BioHeart prices IPO to raise up to $70M

© 2008, TechJournal. All rights reserved.